other disease – Page 8 – Communicable Diseases Research

Impact of the COVID-19 Pandemic on Cancer Diagnoses in General and Specialized Practices in Germany

Article

Published on 2021-01-222022-10-31
Journal: Cancers [Category] COVID-19,

Cardiovascular Deaths During the COVID-19 Pandemic in the United States

Observational Study

Published on 2021-01-192022-10-05
Journal: Journal of the American College of Cardiology [Category] 임상,

[키워드] 1.26 acute respiratory syndrome cardiovascular cardiovascular condition cardiovascular disease cause caused center Cerebrovascular disease change circulatory system condition conducted coronavirus disease Coronavirus disease 2019 Coronavirus-2 COVID-19 COVID-19 pandemic death declined disease evaluate Factors health care systems heart failure hospital hypertensive increase in increases in indirect effect initial ischemic heart disease Massachusett Mortality New New York New York City Observational cohort study occurred Other other disease pandemic Patient raising Region SARS-CoV-2 state Statistics the United State The United States
[DOI] 10.1016/j.jacc.2020.10.055 PMC 바로가기 [Article Type] Observational Study

Can Optimum Solar Radiation Exposure or Supplemented Vitamin D Intake Reduce the Severity of COVID-19 Symptoms?

Review

Published on 2021-01-162022-10-30
Journal: International Journal of Environmental Research an [Category] COVID-19, MERS,

Imaging of COVID-19 simulators

Research

Published on 2021-01-052022-10-31
Journal: The Egyptian Journal of Radiology and Nuclear Medicine [Category] COVID-19,

Meta-analysis of transcriptome datasets: An alternative method to study IL-6 regulation in coronavirus disease 2019

Research Article

Published on 2020-12-242022-10-31
Journal: Computational and Structural Biotechnology Journal [Category] COVID-19,

Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?

Short communication

Published on 2020-12-012022-10-05
Journal: Biochimie [Category] 치료제,

[키워드] acute respiratory distress Antibiotics antiretroviral antiviral agent Bacterial contributed coronavirus disease COVID-19 COVID-19 patients cytochrome P450 Cytokine storm death disease drug Drug hepatotoxicity Drug-induced liver injury Enzymes Epidemic Factors Fatty liver fibrosis fungal healthy individual hepatotoxic higher risk Hospitalized Hypothesis induce insulin resistance lipid homeostasis liver main mechanism mechanism metabolic disease mitochondrial dysfunction multi-organ failure NASH non-infected obese COVID-19 patient obese COVID-19 patients obesity other disease oxidative stress participated Patient patients receive Remdesivir required risk severity steatohepatitis steatosis syndrome systemic inflammation treat
[DOI] 10.1016/j.biochi.2020.08.018 [Article Type] Short communication

Differential impact of BTK active site inhibitors on the conformational state of full-length BTK

Research Article

Published on 2020-11-232022-10-31
Journal: eLife [Category] Coronavirus, SARS,

[키워드] activated Affect allergy Allostery antibodies approved Asthma B cell B-cell B-cells bind binding Blood bruton tyrosine kinase BTK BTK inhibitor BTK inhibitors Cancer Cancer cells cancers catalytic activity change Chemotherapy conformational consequence COVID-19 Diseases disorder disrupt disrupting domain domains drug drug resistance drugs Effect effective enzyme examined FIVE full-length full-length protein Future help hydrogen/deuterium exchange mass spectrometry Ibrutinib inactive increase inhibitor inhibitors Interaction Joseph Kinase inhibitor leukemia lymphoma lymphomas maintain mechanism modify Mutation None not affect nuclear magnetic resonance other compound other disease phosphate Previous effort Protein Proteins Region regions Regulatory regulatory domain regulatory region Research responsible shifting treat treated treating COVID-19 Treatment treatment strategy tyrosine understanding while White blood cell
[DOI] 10.7554/eLife.60470 PMC 바로가기 [Article Type] Research Article

Obesity and the increased risk for COVID-19: mechanisms and nutritional management

Review Article

Published on 2020-11-132022-10-29
Journal: Nutrition Research Reviews [Category] COVID-19, SARS,

[키워드] ACE, angiotensin-converting enzyme adaptive immune responses addition Alter available data CCL, chemokine (C-C motif) ligand co-morbidity combating complex component contribute coronavirus coronavirus disease COVID-19 COVID-19 complications COVID-19, Coronavirus disease 2019 creating diabete DIO, diet-induced obesity excess explain hypertension ICU, Intensive care unit immune response immune system Immunity increased risk induce Infection Inflammation M1, classical macrophages management mechanism morbidity and mortality nutritional status obesity other disease overlap overweight PAI-1, plasminogen activator inhibitor-1 pandemic patients with obesity public health risk risk factor SARS-CoV-2 SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 severe COVID-19 severity Support tissue disruption Trigger viral infection viral infections with COVID-19 worse prognosis
[DOI] 10.1017/S095442242000027X PMC 바로가기 [Article Type] Review Article

Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking

COVID-19에 대한 용도 변경 치료제: 머신 러닝 및 도킹을 통해 상업적으로 이용 가능한 약물의 신속한 예측

Research Article

Published on 2020-11-122022-08-13
Journal: PLoS ONE [Category] Biochemistry, COVID-19, MERS, SARS,

[키워드] accelerate Accuracy Amprenavir antiretroviral drug approach approved can be used caused clinical recovery clinical trial clinical trials Community coronavirus disease COVID-19 COVID-19 treatment criterion disease docking drug drug design Drug discovery DrugBank drugs effective Epidemic epidemic disease FDA futuristic smart drug designing strategy globe help improvement infected case machine learning market medication ML model mortality rate Naive Bayes algorithm new drug combination new virus Novel coronavirus novel coronavirus disease other disease other diseases outbreak predict protocol protocols Rapid reported repurposing required researcher SARS-CoV-2 SARS-CoV-2 virus selected selective Spread the disease the SARS-CoV-2 virus therapeutic agent therapeutic agents treat Treatment treatment of COVID-19 treatment regimen treatment regimens Vaccines virus
[DOI] 10.1371/journal.pone.0241543 PMC 바로가기 [Article Type] Research Article

A Drive-through Simulation Tool for Mass Vaccination during COVID-19 Pandemic

Article

Published on 2020-11-092022-10-31
Journal: International journal for equity in health [Category] COVID-19,